Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...
A significant breakthrough in cross-blockchain technology has been unveiled, integrating Ethereum dApps onto the Bitcoin network. This advancement, enabled by ...